Drug Type Small molecule drug |
Synonyms- |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), H1 receptor antagonists(Histamine H1 receptor antagonists), NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (08 Oct 2024), |
Regulation- |
Molecular FormulaC10H16ClNO |
InChIKeyBALXUFOVQVENIU-KXNXZCPBSA-N |
CAS Registry345-78-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Common Cold | KR | 08 Oct 2024 |